Cited by 1,709Antibiotic Resistance in BacteriaAntibiotics Pharmacokinetics and EfficacySynthesis of β-Lactam Compounds

The DOI matches its Crossref record; 462 of the 464 references it cites were found in a registry or an index.

Three Decades of β-Lactamase Inhibitors

Open access

Drawz, Sarah M., Bonomo, Robert A.·2010·Clinical Microbiology Reviews

Open this paper in CoChat — free account

Abstract

Since the introduction of penicillin, beta-lactam antibiotics have been the antimicrobial agents of choice. Unfortunately, the efficacy of these life-saving antibiotics is significantly threatened by bacterial beta-lactamases. beta-Lactamases are now responsible for resistance to penicillins, extended-spectrum cephalosporins, monobactams, and carbapenems. In order to overcome beta-lactamase-mediated resistance, beta-lactamase inhibitors (clavulanate, sulbactam, and tazobactam) were introduced into clinical practice. These inhibitors greatly enhance the efficacy of their partner beta-lactams (amoxicillin, ampicillin, piperacillin, and ticarcillin) in the treatment of serious Enterobacteriaceae and penicillin-resistant staphylococcal infections. However, selective pressure from excess antibiotic use accelerated the emergence of resistance to beta-lactam-beta-lactamase inhibitor combinations. Furthermore, the prevalence of clinically relevant beta-lactamases from other classes that are resistant to inhibition is rapidly increasing. There is an urgent need for effective inhibitors that can restore the activity of beta-lactams. Here, we review the catalytic mechanisms of each beta-lactamase class. We then discuss approaches for circumventing beta-lactamase-mediated resistance, including properties and characteristics of mechanism-based inactivators. We next highlight the mechanisms of action and salient clinical and microbiological features of beta-lactamase inhibitors. We also emphasize their therapeutic applications. We close by focusing on novel compounds and the chemical features of these agents that may contribute to a "second generation" of inhibitors. The goal for the next 3 decades will be to design inhibitors that will be effective for more than a single class of beta-lactamases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1128/cmr.00037-09

Cites

462 of 462 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Items 201–400 of 462

Monobactams--monocyclic -lactam antibiotics produced by bacteria
SYKES, R. B., BONNER, D. P., Bush, K., Georgopapadakou, N. H., & WELLS, J. S. (1981) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/8.suppl_e.1 · Cited by 101
Genetic and Structural Insights into the Dissemination Potential of the Extremely Broad-Spectrum Class A β-Lactamase KPC-2 Identified in an Escherichia coli Strain and an Enterobacter cloacae Strain Isolated from the Same Patient in France
Petrella, S., Gelus, N., Mayer, C., Renard, M., Jarlier, V., & Sougakoff, W. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00163-08 · Cited by 100
The role of outer membrane and efflux pumps in the resistance of gram-negative bacteria. Can we improve drug access?
Nikaido, H. (1998) · Drug Resistance Updates · doi:10.1016/s1368-7646(98)80023-x · Cited by 98
Siderophore-Antibiotic Conjugates Used as Trojan Horses Against Pseudomonas aeruginosa
Budzikiewicz, H. (2001) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026013395524 · Cited by 98
Determinants of the activity of -lactamase inhibitor combinations
Livermore, D. M. (1993) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/31.suppl_a.9 · Cited by 98
Site-directed mutagenesis at the active site of Escherichia coli TEM-1 beta-lactamase. Suicide inhibitor-resistant mutants reveal the role of arginine 244 and methionine 69 in catalysis.
Delaire, M., Labia, R., Samama, J., & Masson, J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36729-8 · Cited by 97
The acyl-enzyme mechanism of β-lactamase action. The evidence for class C β-lactamases
Knott-Hunziker, V., Petursson, S., Waley, S. G., Jaurin, B., & Grundström, T. (1982) · Biochemical Journal · doi:10.1042/bj2070315 · Cited by 96
In vitro evaluation of BRL 42715, a novel beta-lactamase inhibitor
Coleman, K., Griffin, D. R., Page, J., & Upshon, P. A. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.9.1580 · Cited by 96
-Lactamase Inhibition and In Vitro Activity of Sulbactam and Sulbactam/Cefoperazone
Williams, J. D. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.3.494 · Cited by 95
Site-directed Mutagenesis of Glutamate 166 in Two β-Lactamases
Guillaume, G., Vanhove, M., Lamotte‐Brasseur, J., Ledent, P., Jamin, M., Joris, B., & Frère, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.9.5438 · Cited by 94
Crystallographic Investigation of the Inhibition Mode of a VIM-2 Metallo-β-lactamase from Pseudomonas aeruginosa by a Mercaptocarboxylate Inhibitor
Yamaguchi, Y., Jin, W., Matsunaga, K., Ikemizu, S., Yamagata, Y., Wachino, J.-I., Shibata, N., Arakawa, Y., & Kurosaki, H. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm701031n · Cited by 93
Trifluoromethyl alcohol and ketone inhibitors of metallo-β-lactamases
Walter, M. W., Felici, A., Galleni, M., Soto, R. P., Adlington, R. M., Baldwin, J. E., Frère, J., Gololobov, M. Y., & Schofield, C. J. (1996) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(96)00453-2 · Cited by 91
A semi-synthetic penicillinase inactivator
Cartwright, S. J., & Coulson, A. F. W. (1979) · Nature · doi:10.1038/278360a0 · Cited by 91
Interactions of tazobactam and clavulanate with inducibly- and constitutively-expressed Class I β-lactamases
Akova, M., Yang, Y., & Livermore, D. M. (1990) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/25.2.199 · Cited by 90
Outbreaks in Distinct Regions Due to a Single Klebsiella pneumoniae Clone Carrying a bla VIM-1 Metallo-β-Lactamase Gene
Ikonomidis, A., Tokatlidou, D., Kristo, I., Sofianou, D., Tsakris, A., Mantzana, P., Pournaras, S., & Maniatis, A. N. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.10.5344-5347.2005 · Cited by 90
Structural Insights into the Design of Inhibitors for the L1 Metallo-β-lactamase from Stenotrophomonas maltophilia
Nauton, L., Kahn, R., Garau, G., Hernandez, J., & Dideberg, O. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.10.036 · Cited by 90
nalB-type mutations causing the overexpression of the MexAB-OprM efflux pump are located in themexRgene of thePseudomonas aeruginosachromosome
Saito, K., Hiroshi Yoneyama, C., & Nakae, T. (1999) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1999.tb08709.x · Cited by 90
Structure-based design of a potent transition state analogue for TEM-1 β-lactamase
Strynadka, N. C. J., Martin, R., Jensen, S. E., Gold, M. H., & Jones, J. B. (1996) · Nature Structural & Molecular Biology · doi:10.1038/nsb0896-688 · Cited by 89
Mechanisms of Decreased Susceptibility to Cefpodoxime in Escherichia coli
Oliver, A., Weigel, L. M., Rasheed, J. K., McGowan, J. E., Raney, P. M., & Tenover, F. C. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.12.3829-3836.2002 · Cited by 88
Molecular mechanism of ferricsiderophore passage through the outer membrane receptor proteins of Escherichia coli
Chakraborty, R., Storey, E. P., & der Helm, D. V. (2006) · BioMetals · doi:10.1007/s10534-006-9060-9 · Cited by 88
The Deacylation Mechanism of AmpC β-Lactamase at Ultrahigh Resolution
Chen, Y., Minasov, G., Roth, T. A., Prati, F., & Shoichet, B. K. (2006) · Journal of the American Chemical Society · doi:10.1021/ja056806m · Cited by 87
Resistance to ticarcillin-potassium clavulanate among clinical isolates of the family Enterobacteriaceae: role of PSE-1 beta-lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion tests
Sanders, C. C., Iaconis, J. P., Bodey, G. P., & Samonis, G. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.9.1365 · Cited by 87
Energetic, structural, and antimicrobial analyses of β-lactam side chain recognition by β-lactamases
Caselli, E., Powers, R. A., Blasczcak, L. C., Wu, C. Y. E., Prati, F., & Shoichet, B. K. (2001) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00052-1 · Cited by 87
β‐Lactamase inhibitors
Cartwright, S. J., & Waley, S. G. (1983) · Medicinal Research Reviews · doi:10.1002/med.2610030402 · Cited by 87
β-Lactamase inactivation by mechanism-based reagents
Fisher, J. W., Belasco, J. G., Charnas, R. L., Khosla, S., & Knowles, J. R. (1980) · Philosophical transactions of the Royal Society of London. Series B, Biological sciences · doi:10.1098/rstb.1980.0048 · Cited by 86
Interactions of Ceftobiprole with β-Lactamases from Molecular Classes A to D
Queenan, A. M., Shang, W., Kania, M., Page, M. G. P., & Bush, K. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00218-07 · Cited by 86
Epidemiological Survey of Amoxicillin-Clavulanate Resistance and Corresponding Molecular Mechanisms in Escherichia coli Isolates in France: New Genetic Features of bla TEM Genes
Leflon‐Guibout, V., Speldooren, V., Heym, B., & Nicolas-Chanoine, M.-H. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.10.2709-2714.2000 · Cited by 85
X-ray Analysis of the NMC-A β-Lactamase at 1.64-Å Resolution, a Class A Carbapenemase with Broad Substrate Specificity
Swarén, P., Maveyraud, L., Raquet, X., Cabantous, S., Duez, C., Pédelacq, J. D., Mariotte-Boyer, S., Mourey, L., Labia, R., Nicolas-Chanoine, M.-H., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26714 · Cited by 85
Inhibition of the SHV-1 β-Lactamase by Sulfones: Crystallographic Observation of Two Reaction Intermediates with Tazobactam,
Kuzin, A. P., Nukaga, M., Nukaga, Y., Hujer, A. M., Bonomo, R. A., & Knox, J. R. (2001) · Biochemistry · doi:10.1021/bi0022745 · Cited by 83
Self-citation
A Structure-Based Analysis of the Inhibition of Class A .beta.-Lactamases by Sulbactam
Imtiaz, U., Billings, E. M., Knox, J. R., & Mobashery, S. (1994) · Biochemistry · doi:10.1021/bi00185a009 · Cited by 83
Chemical studies on the inactivation of Escherichia coli RTEM β-lactamase by clavulanic acid
Charnas, R. L., Fisher, J. F., & Knowles, J. R. (1978) · Biochemistry · doi:10.1021/bi00604a025 · Cited by 83
Crystal Structure of Extended-Spectrum β-Lactamase Toho-1: Insights into the Molecular Mechanism for Catalytic Reaction and Substrate Specificity Expansion,
Shimizu‐Ibuka, A., Ishii, Y., Galleni, M., Ishiguro, M., Yamaguchi, K., Frère, J., Matsuzawa, H., & Sakai, H. (2003) · Biochemistry · doi:10.1021/bi0342822 · Cited by 82
RESISTANCE TO BETA-LACTAM/CLAVULANATE
Martínez, J. L., Cercenado, E., Rodríguez‐Créixems, M., Vincente-Perez, M. F., Delgado‐Iribarren, A., & Baquero, F. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91180-9 · Cited by 82
The complexed structure and antimicrobial activity of a non‐β‐lactam inhibitor of AmpC β‐lactamase
Powers, R. A., Blázquez, J., Weston, G. S., Shoichet, B. K., Morosini, M.-I., & Baquero, F. (1999) · Protein Science · doi:10.1110/ps.8.11.2330 · Cited by 82
High-Resolution X-ray Structure of an Acyl-Enzyme Species for the Class D OXA-10 β-Lactamase
Maveyraud, L., Golemi, D., Ishiwata, A., Meroueh, O., Mobashery, S., & Samama, J. (2002) · Journal of the American Chemical Society · doi:10.1021/ja016736t · Cited by 80
Combined Activity of Clavulanic Acid and Ticarcillin Against Ticarcillin-Resistant, Gram-Negative Bacilli
Paisley, J. W., & Washington, J. A. (1978) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.14.2.224 · Cited by 80
Structure−Activity Relationship of 6-Methylidene Penems Bearing Tricyclic Heterocycles as Broad-Spectrum β-Lactamase Inhibitors: Crystallographic Structures Show Unexpected Binding of 1,4-Thiazepine Intermediates
Venkatesan, A. M., Gu, Y., dos Santos, O., Abé, T., Agarwal, A. K., Yang, Y., Petersen, P. J., Weiss, W. J., Mansour, T. S., Nukaga, M., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049680x · Cited by 79
Self-citation
Mixed Quantum Mechanical/Molecular Mechanical (QM/MM) Study of the Deacylation Reaction in a Penicillin Binding Protein (PBP) versus in a Class C β-Lactamase
Gherman, B. F., Goldberg, S. D., Cornish, V. W., & Friesner, R. A. (2004) · Journal of the American Chemical Society · doi:10.1021/ja036879a · Cited by 79
Design, Synthesis, and Evaluation of 2β-Alkenyl Penam Sulfone Acids as Inhibitors of β-Lactamases
Richter, H. G., Angehrn, P., Hubschwerlen, C., Kania, M., Page, M. G. P., Specklin, J., & Winkler, F. K. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm9601967 · Cited by 79
Inhibition of Class A β-Lactamases by Carbapenems: Crystallographic Observation of Two Conformations of Meropenem in SHV-1
Nukaga, M., Bethel, C. R., Thomson, J. M., Hujer, A. M., Distler, A. M., Anderson, V. E., Knox, J. R., & Bonomo, R. A. (2008) · Journal of the American Chemical Society · doi:10.1021/ja7111146 · Cited by 78
Self-citation
Structural Basis for Imipenem Inhibition of Class C β-Lactamases
Beadle, B. M., & Shoichet, B. K. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.12.3978-3980.2002 · Cited by 78
Diffusion-limited component of reactions catalyzed by Bacillus cereus .beta.-lactamase I
Hardy, L. W., & Kirsch, J. F. (1984) · Biochemistry · doi:10.1021/bi00301a040 · Cited by 77
In vitro activity of ticarcillin plus clavulanic acid against 632 clinical isolates
FUCHS, P. C., Barry, A. L., Thornsberry, C., & Jones, R. N. (1984) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.25.3.392 · Cited by 77
Penicillin-derived inhibitors that simultaneously target both metallo- and serine-β-lactamases
Buynak, J. D., Chen, H., Vogeti, L., Gadhachanda, V. R., Buchanan, C. A., Palzkill, T. G., Shaw, R. W., SPENCER, J. M., & Walsh, T. R. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.12.037 · Cited by 77
Catalytic Mechanism of Class B2 Metallo-β-lactamase
Xu, D., Xie, D., & Guo, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512517200 · Cited by 76
Structure of a Phosphonate-inhibited β-Lactamase
Chen, C. C. H., Rahil, J. F., Pratt, R. F., & Herzberg, O. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1571 · Cited by 75
Structure-Based Design of β-Lactamase Inhibitors. 1. Synthesis and Evaluation of Bridged Monobactams
Heinze‐Krauss, I., Angehrn, P., Charnas, R. L., Gubernator, K., Gutknecht, E.-M., Hubschwerlen, C., Kania, M., Oefner, C., Page, M. G. P., Sogabe, S., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm980023c · Cited by 75
Clinical Correlation of the CLSI Susceptibility Breakpoint for Piperacillin- Tazobactam against Extended-Spectrum-β-Lactamase-Producing Escherichia coli and Klebsiella Species
Gavin, P. J., Suseno, M. T., Thomson, R. B., Gaydos, J. M., Pierson, C. L., Halstead, D. C., Aslanzadeh, J., Brecher, S. M., Rotstein, C., Brossette, S. E., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00381-05 · Cited by 75
The Structural Bases of Antibiotic Resistance in the Clinically Derived Mutant β-Lactamases TEM-30, TEM-32, and TEM-34
Wang, X., Minasov, G., & Shoichet, B. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204212200 · Cited by 75
Sulbactam-containing β-lactamase inhibitor combinations
Akova, M. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01847.x · Cited by 73
High Resolution Crystal Structures of the trans-Enamine Intermediates Formed by Sulbactam and Clavulanic Acid and E166A SHV-1 β-Lactamase
Padayatti, P. S., Helfand, M. S., Totir, M. A., Carey, M. P., CAREY, P. R., Bonomo, R. A., & van den Akker, F. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505333200 · Cited by 73
Self-citation
Inhibition of subtilisin by boronic acids, potential analogs of tetrahedral reaction intermediates
Lindquist, R. N., & Terry, C. (1974) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(74)80018-4 · Cited by 73
b-Lactamase inhibitors
Page, M. G. P. (2000) · Drug Resistance Updates · doi:10.1054/drup.2000.0137 · Cited by 73
SHV-type beta-lactamases.
TZOUVELEKIS, L. S., & Bonomo, R. A. (1999) · PubMed · Cited by 73
Self-citation
Crystal structures of the class D β-lactamase OXA-13 in the native form and in complex with meropenem
Pernot, L., Frénois, F., Rybkine, T., L’Hermite, G., Petrella, S., Delettré, J., Jarlier, V., Collatz, E., & Sougakoff, W. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4805 · Cited by 71
Inhibition of the RTEM .beta.-lactamase from Escherichia coli. Interaction of the enzyme with derivatives of olivanic acid
Easton, C. J., & Knowles, J. R. (1982) · Biochemistry · doi:10.1021/bi00541a008 · Cited by 71
Effect of hyperproduction of TEM-1 beta-lactamase on in vitro susceptibility of Escherichia coli to beta-lactam antibiotics
Wu, P. J., Shannon, K. P., & Phillips, I. R. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.3.494 · Cited by 71
Variety of β-Lactamases Produced by Amoxicillin-Clavulanate-Resistant Escherichia coli Isolated in the Northeastern United States
Kaye, K. S., Gold, H. S., Schwaber, M. J., Venkataraman, L., Qi, Y., Girolami, P. C. D., Samore, M. H., Anderson, G., Rasheed, J. K., & Tenover, F. C. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1520-1525.2004 · Cited by 71
Enzyme-mediated resistance to antibiotics: mechanisms, dissemination, and prospects for inhibition.
Bonomo, R. A., & Tolmasky, M. E. (2007) · Cited by 70
Self-citation
Structural Consequences of the Inhibitor-Resistant Ser130Gly Substitution in TEM β-Lactamase,
Thomas, V. L., Golemi, D., Kim, C. K., Vakulenko, S. B., Mobashery, S., & Shoichet, B. K. (2005) · Biochemistry · doi:10.1021/bi0502700 · Cited by 70
Three Decades of the Class A β-Lactamase Acyl-Enzyme
Fisher, J. F., & Mobashery, S. (2009) · Current Protein and Peptide Science · doi:10.2174/138920309789351967 · Cited by 70
Clavulanate Induces Expression of the Pseudomonas aeruginosa AmpC Cephalosporinase at Physiologically Relevant Concentrations and Antagonizes the Antibacterial Activity of Ticarcillin
Lister, P., Gardner, V. M., & Sanders, C. C. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.4.882 · Cited by 70
Orthodox and unorthodox clavulanate combinations against extended-spectrum β-lactamase producers
Livermore, D. M., Hope, R., Mushtaq, S., & Warner, M. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01858.x · Cited by 70
Clavulanic Acid Inactivation of SHV-1 and the Inhibitor-resistant S130G SHV-1 β-Lactamase
Sulton, D. L., Pagán-Rodríguez, D., Zhou, X. Y., Liu, Y., Hujer, A. M., Bethel, C. R., Helfand, M. S., Thomson, J. M., Anderson, V. E., Buynak, J. D., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501251200 · Cited by 70
Self-citation
Tazobactam Forms a Stoichiometric trans-Enamine Intermediate in the E166A Variant of SHV-1 β-Lactamase: 1.63 Å Crystal Structure,
Padayatti, P. S., Helfand, M. S., Totir, M. A., Carey, M. P., Hujer, A. M., CAREY, P. R., Bonomo, R. A., & van den Akker, F. (2004) · Biochemistry · doi:10.1021/bi035985m · Cited by 69
Self-citation
Carbapenem Derivatives as Potential Inhibitors of Various β-Lactamases, Including Class B Metallo-β-Lactamases
Nagano, R., Adachi, Y., Imamura, H., Yamada, K., Hashizume, T., & Morishima, H. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.10.2497 · Cited by 69
Inhibition of the RTEM .beta.-lactamase from Escherichia coli. Interaction of the enzyme with derivatives of olivanic acid
Charnas, R. L., & Knowles, J. R. (1981) · Biochemistry · doi:10.1021/bi00513a005 · Cited by 69
Hydrolysis of Third-generation Cephalosporins by Class C β-Lactamases
Nukaga, M., Kumar, S., Nukaga, K., Pratt, R. F., & Knox, J. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312356200 · Cited by 68
Understanding Resistance to β-Lactams and β-Lactamase Inhibitors in the SHV β-Lactamase
Helfand, M. S., Bethel, C. R., Hujer, A. M., Hujer, K. M., Anderson, V. E., & Bonomo, R. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306059200 · Cited by 68
Self-citation
Following the Reactions of Mechanism-Based Inhibitors with β-Lactamase by Raman Crystallography
Helfand, M. S., Totir, M. A., Carey, M. P., Hujer, A. M., Bonomo, R. A., & CAREY, P. R. (2003) · Biochemistry · doi:10.1021/bi035716w · Cited by 68
Self-citation
Nuances of Mechanisms and Their Implications for Evolution of the Versatile β-Lactamase Activity: From Biosynthetic Enzymes to Drug Resistance Factors
Bulychev, A., Massova, I., Miyashita, K., & Mobashery, S. (1997) · Journal of the American Chemical Society · doi:10.1021/ja963708f · Cited by 67
Mono‐ and binuclear Zn‐β‐lactamase from Bacteroides fragilis: catalytic and structural roles of the zinc ions
Soto, R. P., Hernandez-Valladares, M., Galleni, M., Bauer, R., Zeppezauer, M. M., Frère, J., & Adolph, H. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01289-7 · Cited by 67
Inactivation of radiolabeled RTEM .beta.-lactamase from Escherichia coli by clavulanic acid and 9-deoxyclavulanic acid
Charnas, R. L., & Knowles, J. R. (1981) · Biochemistry · doi:10.1021/bi00514a035 · Cited by 67
The High Resolution Crystal Structure for Class A β-Lactamase PER-1 Reveals the Bases for Its Increase in Breadth of Activity
Tranier, S., Bouthors, A.-T., Maveyraud, L., Guillet, V., Sougakoff, W., & Samama, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003802200 · Cited by 66
Catalytic mechanism of active-site serine β-lactamases: role of the conserved hydroxy group of the Lys-Thr(Ser)-Gly triad
Dubus, A., Wilkin, J., Raquet, X., Normark, S. J., & Frère, J. (1994) · Biochemical Journal · doi:10.1042/bj3010485 · Cited by 65
Frequency of inhibitor-resistant TEM β-lactamases in Escherichia coli isolates from urinary tract infections in Fran
Henquell, C., Sirot, D., Chanal, C., de Champs, C., Chatron, P., Lafeuille, B., Texier, P., Sirof, J., & Cluzel, R. A. (1994) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/34.5.707 · Cited by 65
Evidence for an oxyanion hole in serine β-lactamases and dd -peptidases
Murphy, B. P., & Pratt, R. F. (1988) · Biochemical Journal · doi:10.1042/bj2560669 · Cited by 65
In vitro efficacy of sulbactam combined with ampicillin against anaerobic bacteria
Wexler, H. M., Harris, B., Carter, W. T., & Finegold, S. M. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.27.5.876 · Cited by 64
Structure-Based Optimization of a Non-β-lactam Lead Results in Inhibitors That Do Not Up-Regulate β-Lactamase Expression in Cell Culture
Tondi, D., Morandi, F., Bonnet, R., Costi, M. P., & Shoichet, B. K. (2005) · Journal of the American Chemical Society · doi:10.1021/ja042984o · Cited by 64
Selection and Characterization of β-Lactam–β-Lactamase Inactivator-Resistant Mutants following PCR Mutagenesis of the TEM-1 β-Lactamase Gene
Vakulenko, S. B., Geryk, B., Kotra, L. P., Mobashery, S., & Lerner, S. A. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.7.1542 · Cited by 63
Inhibition of Class A and Class C β-Lactamases by Penems: Crystallographic Structures of a Novel 1,4-Thiazepine Intermediate,
Nukaga, M., Abé, T., Venkatesan, A. M., Mansour, T. S., Bonomo, R. A., & Knox, J. R. (2003) · Biochemistry · doi:10.1021/bi034986b · Cited by 63
Self-citation
Further observations on penicillin. 1941.
Abraham, E. P., Chain, E. B., Cm, F., Florey, H. W., Ad, G., HEATLEY, N. G., & Ma, J. (1992) · PubMed · Cited by 62
Antibiotic policy and prescribing strategies for therapy of extended-spectrum β-lactamase-producing Enterobacteriaceae: the role of piperacillin–tazobactam
Peterson, L. R. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01864.x · Cited by 62
Improved methods for the preparation of high molecular weight DNA from large and small scale cultures of filamentous fungi
Bainbridge, B. W. (1990) · FEMS Microbiology Letters · doi:10.1016/0378-1097(90)90267-t · Cited by 62
Penicillin-binding proteins and ampicillin resistance in Haemophilus influenzae
Mendelman, P. M., Chaffin, D. O., & Kalaitzoglou, G. (1990) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/25.4.525 · Cited by 62
Inhibition of Class C β-Lactamases: Structure of a Reaction Intermediate with a Cephem Sulfone,
Crichlow, G. V., Nukaga, M., Doppalapudi, V. R., Buynak, J. D., & Knox, J. R. (2001) · Biochemistry · doi:10.1021/bi010131s · Cited by 62
The 1.4 Å Crystal Structure of the Class D β-Lactamase OXA-1 Complexed with Doripenem
Schneider, K. D., Karpen, M. E., Bonomo, R. A., Leonard, D. A., & Powers, R. A. (2009) · Biochemistry · doi:10.1021/bi901690r · Cited by 62
Self-citation
Competitive Inhibitors of the CphA Metallo-β-Lactamase from Aeromonas hydrophila
Horsfall, L., Garau, G., Liénard, B. M. R., Dideberg, O., Schofield, C. J., Frère, J.-M., & Galleni, M. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00866-06 · Cited by 62
Risk Factors for Recovery of Ampicillin-Sulbactam-Resistant Escherichia coli in Hospitalized Patients
Kaye, K. S., Harris, A. D., Gold, H. S., & Carmeli, Y. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.1004-1009.2000 · Cited by 61
Mutagenesis of amino acid residues in the SHV-1 β-lactamase: the premier role of Gly238Ser in penicillin and cephalosporin resistance
Hujer, A. M., Hujer, K. M., & Bonomo, R. A. (2001) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(01)00164-9 · Cited by 61
Self-citation
Insights into the Acylation Mechanism of Class A β-Lactamases from Molecular Dynamics Simulations of the TEM-1 Enzyme Complexed with Benzylpenicillin
Díaz, N., Sordo, T. L., Merz, K. M., & Suárez, D. (2002) · Journal of the American Chemical Society · doi:10.1021/ja027704o · Cited by 59
Probing Active Site Chemistry in SHV β-Lactamase Variants at Ambler Position 244
Thomson, J. M., Distler, A. M., Prati, F., & Bonomo, R. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603222200 · Cited by 59
Self-citation
Multiple substitutions at position 104 of β-lactamase TEM-1: assessing the role of this residue in substrate specificity
Petit-Paitel, A., Maveyraud, L., Lenfant, F., Samama, J., Labia, R., & Masson, J. (1995) · Biochemical Journal · doi:10.1042/bj3050033 · Cited by 59
Protonation of the β-lactam nitrogen is the trigger event in the catalytic action of class A β-lactamases
Atanasov, B. P., Mustafi, D., & Makinen, M. W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3160 · Cited by 59
Replacement of Broad-Spectrum Cephalosporins by Piperacillin-Tazobactam: Impact on Sustained High Rates of Bacterial Resistance
Bantar, C., Vesco, E., Heft, C., Salamone, F., Krayeski, M., Gomez, H., Coassolo, M. A., Fiorillo, A., Franco, D., Arango, C., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.2.392-395.2004 · Cited by 58
Pharmacokinetics and tissue penetration of cefepime
Nye, K., Shi, Y. G., Andrews, J. M., & Wise, R. A. (1989) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/24.1.23 · Cited by 58
New leads of metallo-β-lactamase inhibitors from structure-based pharmacophore design
Olsen, L., Jost, S., Adolph, H., Pettersson, I., Hemmingsen, L., & Jørgensen, F. S. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.11.046 · Cited by 58
SHV-Type β-Lactamases
TZOUVELEKIS, L. S., & Bonomo, R. A. (1999) · Current Pharmaceutical Design · doi:10.2174/1381612805666230112183734 · Cited by 58
Self-citation
Enhanced resistance to cefotaxime and imipenem associated with outer membrane protein alterations in Enterobacter aerogenes
Hopkins, J., & Towner, K. J. (1990) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/25.1.49 · Cited by 57
Piperacillin/tazobactam (YTR 830) combination. Comparative antimicrobial activity against 5889 recent aerobic clinical isolates and 60 Bacteroides fragilis group strains.
Jones, R. N., Pfaller, M. A., FUCHS, P. C., Aldridge, K. E., Allen, S. D., & Gerlach, E. H. (1989) · PubMed · Cited by 56
Penicillanic acid sulfone: nature of irreversible inactivation of the RTEM .beta.-lactamase from Escherichia coli
Brenner, D. G., & Knowles, J. R. (1984) · Biochemistry · doi:10.1021/bi00319a024 · Cited by 56
Structural and Computational Characterization of the SHV-1 β-Lactamase-β-Lactamase Inhibitor Protein Interface
Reynolds, K. A., Thomson, J. M., Corbett, K. D., Bethel, C. R., Berger, J. M., Kirsch, J. F., Bonomo, R. A., & Handel, T. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603878200 · Cited by 55
Self-citation
Strategic Design of an Effective β-Lactamase Inhibitor
Pattanaik, P., Bethel, C. R., Hujer, A. M., Hujer, K. M., Distler, A. M., Taracila, M. A., Anderson, V. E., Fritsche, T. R., Jones, R. N., Pagadala, S. R. R., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806833200 · Cited by 55
Self-citation
Mechanism of turnover of imipenem by the TEM .beta.-lactamase revisited
Taibi, P., & Mobashery, S. (1995) · Journal of the American Chemical Society · doi:10.1021/ja00134a003 · Cited by 55
Rational Design of a β-Lactamase Inhibitor Achieved via Stabilization of the trans-Enamine Intermediate: 1.28 Å Crystal Structure of wt SHV-1 Complex with a Penam Sulfone
Padayatti, P. S., Sheri, A., Totir, M. A., Helfand, M. S., Carey, M. P., Anderson, V. E., CAREY, P. R., Bethel, C. R., Bonomo, R. A., Buynak, J. D., et al. (2006) · Journal of the American Chemical Society · doi:10.1021/ja063715w · Cited by 55
Self-citation
Cytokines involved in human septic shock--the model of the Jarisch- Herxheimer reaction
Griffin, G. E. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/41.suppl_1.25 · Cited by 55
Small plasmids are involved in amoxicillin-clavulanate resistance in Escherichia coli
Martínez, J. L., Vicente, M. F., Delgado‐Iribarren, A., Pérez-Díaz, J. C., & Baquero, F. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.4.595-a · Cited by 54
Current challenges in antimicrobial chemotherapy: the impact of extended-spectrum β-lactamases and metallo-β-lactamases on the treatment of resistant Gram-negative pathogens
Helfand, M. S., & Bonomo, R. A. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.04.013 · Cited by 53
Self-citation
Kinetic and spectroscopic characterization of native and metal‐substituted β‐lactamase from Aeromonas hydrophila AE036
Hernandez-Valladares, M., Kiefer, M., Heinz, U., Soto, R. P., Meyer‐Klaucke, W., Nolting, H. F., Zeppezauer, M. M., Galleni, M., Frère, J., Rossolini, G. M., et al. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01102-9 · Cited by 53
Inhibitor-Resistant Class A β-Lactamases: Consequences of the Ser130-to-Gly Mutation Seen in Apo and Tazobactam Structures of the SHV-1 Variant,
Sun, T., Bethel, C. R., Bonomo, R. A., & Knox, J. R. (2004) · Biochemistry · doi:10.1021/bi0487903 · Cited by 53
Self-citation
In Vitro and In Vivo Activities of Novel 6-Methylidene Penems as β-Lactamase Inhibitors
Weiss, W. J., Petersen, P. J., Murphy, T. M., Tardio, L., Yang, Y., Bradford, P. A., Venkatesan, A. M., Abé, T., Isoda, T., Mihira, A., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4589-4596.2004 · Cited by 53
Tazobactam Inactivation of SHV-1 and the Inhibitor-resistant Ser130 → Gly SHV-1 β-Lactamase
Pagán-Rodríguez, D., Zhou, X., Simmons, R., Bethel, C. R., Hujer, A. M., Helfand, M. S., Jin, Z., Guo, B., Anderson, V. E., Ng, L., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311669200 · Cited by 53
Self-citation
The semi-synthetic thienamycin derivative MK0787 and its properties with respect to a range of β-lactamases from clinically relevant bacterial species
Richmond, M. H. (1981) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/7.3.279 · Cited by 52
Structure of the imipenem-hydrolyzing class A β-lactamase SME-1 fromSerratia marcescens
Sougakoff, W., L’Hermite, G., Pernot, L., Naas, T., Guillet, V., Nordmann, P., Jarlier, V., & Delettré, J. (2002) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444901019606 · Cited by 52
A catalytically-impaired class A β-lactamase: 2 Å crystal structure and kinetics of the Bacillus licheniformis E166A mutant
Knox, J. R., Moews, P. C., Escobar, W. A., & Fink, A. L. (1993) · Protein Engineering Design and Selection · doi:10.1093/protein/6.1.11 · Cited by 51
Dissecting the Protein-Protein Interface between β-Lactamase Inhibitory Protein and Class A β-Lactamases
Zhang, Z., & Palzkill, T. G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406157200 · Cited by 51
Effect of the Inhibitor-Resistant M69V Substitution on the Structures and Populations of trans-Enamine β-Lactamase Intermediates
Totir, M. A., Padayatti, P. S., Helfand, M. S., Carey, M. P., Bonomo, R. A., CAREY, P. R., & van den Akker, F. (2006) · Biochemistry · doi:10.1021/bi060990m · Cited by 51
Self-citation
Molecular Dynamics at the Root of Expansion of Function in the M69L Inhibitor-Resistant TEM β-Lactamase from Escherichia coli
Meroueh, S. O., Roblin, P., Golemi, D., Maveyraud, L., Vakulenko, S. B., Zhang, Y., Samama, J., & Mobashery, S. (2002) · Journal of the American Chemical Society · doi:10.1021/ja026547q · Cited by 51
Electrostatic analysis of TEM1 β-lactamase: effect of substrate binding, steep potential gradients and consequences of site-directed mutations
Swarén, P., Maveyraud, L., Guillet, V., Masson, J., Mourey, L., & Samama, J. (1995) · Structure · doi:10.1016/s0969-2126(01)00194-0 · Cited by 51
Noncovalent interaction energies in covalent complexes: TEM‐1 β‐lactamase and β‐lactams
Wang, X., Minasov, G., & Shoichet, B. K. (2002) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.10058 · Cited by 51
Mutation of the Active Site Carboxy-Lysine (K70) of OXA-1 β-Lactamase Results in a Deacylation-Deficient Enzyme
Schneider, K. D., Bethel, C. R., Distler, A. M., Hujer, A. M., Bonomo, R. A., & Leonard, D. A. (2009) · Biochemistry · doi:10.1021/bi900448u · Cited by 50
Self-citation
Ceftobiprole: An Extended-Spectrum Anti–Methicillin-Resistant Staphylococcus aureus Cephalosporin
Anderson, S. D., & Gums, J. G. (2008) · Annals of Pharmacotherapy · doi:10.1345/aph.1l016 · Cited by 50
Mechanism of Inhibition of the Class A β-Lactamases PC1 and TEM-1 by Tazobactam
Yang, Y., Janota, K., Tabei, K., Huang, N., Siegel, M. M., Lin, Y., Rasmussen, B. A., & Shlaes, D. M. (2000) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61429-8 · Cited by 50
Replacement of lysine 234 affects transition state stabilization in the active site of beta-lactamase TEM1.
Lenfant, F., Labia, R., & Masson, J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47357-2 · Cited by 49
Inhibition of the NMC-A β-Lactamase by a Penicillanic Acid Derivative and the Structural Bases for the Increase in Substrate Profile of This Antibiotic Resistance Enzyme
Mourey, L., Miyashita, K., Swarén, P., Bulychev, A., Samama, J., & Mobashery, S. (1998) · Journal of the American Chemical Society · doi:10.1021/ja9817996 · Cited by 49
Dynamic Combinatorial Mass Spectrometry Leads to Metallo-β-lactamase Inhibitors
Liénard, B. M. R., Hüting, R., Lassaux, P., Galleni, M., Frère, J., & Schofield, C. J. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm070866g · Cited by 49
Contribution of clonal dissemination and selection of mutants during therapy to Pseudomonas aeruginosa antimicrobial resistance in an intensive care unit setting
Juan, C., Gutiérrez, O., Oliver, A., Ayestarán, I., Borrell, N., & Pérez, J. L. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01251.x · Cited by 48
X-ray Structure of the Asn276Asp Variant of the Escherichia coli TEM-1 β-Lactamase: Direct Observation of Electrostatic Modulation in Resistance to Inactivation by Clavulanic Acid,
Swarén, P., Golemi, D., Cabantous, S., Bulychev, A., Maveyraud, L., Mobashery, S., & Samama, J. (1999) · Biochemistry · doi:10.1021/bi990758z · Cited by 48
Implication of Ile-69 and Thr-182 residues in kinetic characteristics of IRT-3 (TEM-32) beta-lactamase
Farzaneh, S., Chaibi, E. B., Péduzzi, J., Barthélémy, M., Labia, R., Blázquez, J., & Baquero, F. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.10.2434 · Cited by 48
Recognition and Resistance in TEM β-Lactamase
Wang, X., Minasov, G., Blázquez, J., Caselli, E., Prati, F., & Shoichet, B. K. (2003) · Biochemistry · doi:10.1021/bi034242y · Cited by 47
The synthesis and evaluation of 6-alkylidene-2'β-substituted penam sulfones as β-lactamase inhibitors
Buynak, J. D., Rao, A. S., Doppalapudi, V. R., Adam, G., Petersen, P. J., & Nidamarthy, S. D. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00325-x · Cited by 46
Enhancing Resistance to Cephalosporins in Class C β-Lactamases: Impact of Gly214Glu in CMY-2
Endimiani, A., Doi, Y., Bethel, C. R., Taracila, M. A., Adams‐Haduch, J. M., O’Keefe, A., Hujer, A. M., Paterson, D. L., Skalweit, M. J., Page, M. G. P., et al. (2009) · Biochemistry · doi:10.1021/bi9015549 · Cited by 46
Self-citation
Inhibition of the Class C β-Lactamase from Acinetobacter spp.: Insights into Effective Inhibitor Design
Drawz, S. M., Babić, M. S., Bethel, C. R., Taracila, M., Distler, A. M., Ori, C., Caselli, E., Prati, F., & Bonomo, R. A. (2009) · Biochemistry · doi:10.1021/bi9015988 · Cited by 46
Self-citation
Association of antibiotic utilization measures and reduced incidence of infections with extended-spectrum beta-lactamase-producing organisms.
Lan, C.-K., Hsueh, P., Wong, W.-W., Fung, C., Lau, Y.-T., Yeung, J. Y. K., Young, G. T., & Su, C. (2003) · PubMed · Cited by 46
Different Intermediate Populations Formed by Tazobactam, Sulbactam, and Clavulanate Reacting with SHV-1 β-Lactamases: Raman Crystallographic Evidence
Kalp, M., Totir, M. A., Buynak, J. D., & CAREY, P. R. (2009) · Journal of the American Chemical Society · doi:10.1021/ja808311s · Cited by 45
Optimizing Cell Permeation of an Antibiotic Resistance Inhibitor for Improved Efficacy
Venturelli, A., Tondi, D., Cancian, L., Morandi, F., Cannazza, G., Segatore, B., Prati, F., Amicosante, G., Shoichet, B. K., & Costi, M. P. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070643q · Cited by 45
Exposure to co-amoxiclav as a risk factor for co-amoxiclav-resistant Escherichia coli urinary tract infection
Leflon‐Guibout, V. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.2.367 · Cited by 45
Synthesis and Biological Activity of 7-Alkylidenecephems
Buynak, J. D., Wu, K., Bachmann, B. O., Khasnis, D. D., Hua, L., Nguyen, H. K., & Carver, C. L. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00006a022 · Cited by 44
When drug inactivation renders the target irrelevant to antibiotic resistance: a case story with β‐lactams
Lakaye, B., Dubus, A., Lepage, S., Groslambert, S., & Frère, J. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01150.x · Cited by 44
Tazobactam is a potent inactivator of selected inhibitor-resistant class A β-lactamases
Bonomo, R. A., Rudin, S., & Shlaes, D. M. (2006) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1997.tb10267.x · Cited by 44
Self-citation
Dipolar Cycloaddition of Novel 6-(Nitrileoxidomethyl) Penam Sulfone: An Efficient Route to a New Class of β-Lactamase Inhibitors
Sandanayaka, V. P., & Yang, Y. (2000) · Organic Letters · doi:10.1021/ol006256r · Cited by 44
Mechanism of inhibition of the class A beta -lactamases PC1 and TEM-1 by tazobactam. Observation of reaction products by electrospray ionization mass spectrometry.
Yang, Y., Janota, K., Tabei, K., Huang, N., Siegel, M. M., Lin, Y., Rasmussen, B. A., & Shlaes, D. M. (2000) · PubMed · doi:10.1074/jbc.m002369200 · Cited by 43
Facilitation of the .DELTA.2 .fwdarw. .DELTA.1 pyrroline tautomerization of carbapenem antibiotics by the highly conserved arginine-244 of class A .beta.-lactamases during the course of turnover
Zafaralla, G. C., & Mobashery, S. (1992) · Journal of the American Chemical Society · doi:10.1021/ja00030a070 · Cited by 43
Characterization of a Salmonella enterica serovar Agona strain harbouring a class 1 integron containing novel OXA-type -lactamase (blaOXA-53) and 6'-N-aminoglycoside acetyltransferase genes [aac(6')-I30]
Mulvey, M. R. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh347 · Cited by 43
Optimizing Therapy for Stenotrophomonas maltophilia
Muder, R. R. (2007) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-2007-996414 · Cited by 41
Structure-Activity Relationship of 6-Methylidene Penems Bearing 6,5 Bicyclic Heterocycles as Broad-Spectrum β-Lactamase Inhibitors: Evidence for 1,4-Thiazepine Intermediates with C7 R Stereochemistry by Computational Methods
Venkatesan, A. M., Agarwal, A. K., Abé, T., Ushirogochi, H., Yamamura, I., Mihira, A., Takasaki, T., dos Santos, O., Gu, Y., Sum, F., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060021p · Cited by 41
Mechanisms of hyperproduction of TEM-1 β-lactamase by clinical isolates of Escherichia coli
Wu, P., Shannon, K. P., & Phillips, I. R. (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/36.6.927 · Cited by 41
O-Aryloxycarbonyl Hydroxamates: New β-Lactamase Inhibitors That Cross-Link the Active Site
Wyrembak, P. N., Babaoglu, K., Pelto, R. B., Shoichet, B. K., & Pratt, R. F. (2007) · Journal of the American Chemical Society · doi:10.1021/ja072370u · Cited by 41
Novel β-lactam antibiotics and inhibitor combinations
Bassetti, M., Righi, E., & Viscoli, C. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.3.285 · Cited by 41
In Vitro Activity of LK-157, a Novel Tricyclic Carbapenem As Broad-Spectrum β-Lactamase Inhibitor
Paukner, S., Hesse, L., Preželj, A., Šolmajer, T., & Urleb, U. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00085-08 · Cited by 41
Prevalence of Clinical Isolates of Escherichia coli Producing Inhibitor-Resistant β-Lactamases at a University Hospital in Barcelona, Spain, over a 3-Year Period
Miró, E., Navarro, F., Mirelis, B., Sabaté, M., Rivera, A., Coll, P., & Prats, G. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.12.3991-3994.2002 · Cited by 41
Piperacillin/tazobactam (YTR 830) combination
Jones, R. N., Pfaller, M. A., FUCHS, P. C., Aldridge, K. E., Allen, S. D., & Gerlach, E. H. (1989) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/0732-8893(89)90083-7 · Cited by 41
Frequency of plasmid-determined beta-lactamases in 680 consecutively isolated strains ofEnterobacteriaceae
Roy, C., Segura, C., Tirado, M., Reig, R., Hermida, M., Teruel, D., & Foz, A. (1985) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02013586 · Cited by 40
The Asparagine to Aspartic Acid Substitution at Position 276 of TEM-35 and TEM-36 Is Involved in the β-Lactamase Resistance to Clavulanic Acid
Saves, I., Burlet‐Schiltz, O., Swarén, P., Lefévre, F., Masson, J., Promé, J., & Samama, J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.31.18240 · Cited by 40
Selective imipenem resistance in Pseudomonas aeruginosa associated with diminished outer membrane permeability
STUDEMEISTER, A. E., & Quinn, J. P. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.8.1267 · Cited by 40
Tazobactam is a potent inactivator of selected inhibitor-resistant class A β-lactamases
Bonomo, R. A. (1997) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(97)00013-x · Cited by 40
Self-citation
Clinical inhibitor-resistant mutants of the β-lactamase TEM-1 at amino-acid position 69
Chaibi, E. B., Péduzzi, J., Farzaneh, S., Barthélémy, M., Sirot, D., & Labia, R. (1998) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(97)00127-1 · Cited by 39
Crystal Structure of BRL 42715, C6-(N1-Methyl-1,2,3-triazolylmethylene)penem, in Complex withEnterobactercloacae908R β-Lactamase: Evidence for a Stereoselective Mechanism from Docking Studies
Michaux, C., Charlier, P., Frère, J., & Wouters, J. (2005) · Journal of the American Chemical Society · doi:10.1021/ja0426241 · Cited by 39
Long-term evolution of a nosocomial outbreak of Pseudomonas aeruginosa producing VIM-2 metallo-enzyme
Corvec, S., Poirel, L., Espaze, E., Giraudeau, C., Drugeon, H., & Nordmann, P. (2008) · Journal of Hospital Infection · doi:10.1016/j.jhin.2007.10.016 · Cited by 39
ChemInform Abstract: Regulation of Inducible AmpC β‐Lactamase Expression Among Enterobacteriaceae
Hanson, N. D., & Sanders, C. C. (2000) · ChemInform · doi:10.1002/chin.200006271 · Cited by 39
The role of lysine-67 in a class C β-lactamase is mainly electrostatic
Monnaie, D., Dubus, A., & Frère, J. (1994) · Biochemical Journal · doi:10.1042/bj3020001 · Cited by 39
The synthesis and evaluation of 3-substituted-7-(alkylidene)cephalosporin sulfones as β-lactamase inhibitors
Buynak, J. D., Doppalapudi, V. R., & Adam, G. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00098-6 · Cited by 38
UREIDOPENICILLINS AND BETA-LACTAM/BETA-LACTAMASE INHIBITOR COMBINATIONS
Bush, L. M., & Johnson, C. C. (2000) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70255-5 · Cited by 38
Kinetic and physical studies of β-lactamase inhibition by a novel penem, BRL 42715
Farmer, T. H., Page, J., Payne, D. J., & KNOWLES, D. J. C. (1994) · Biochemical Journal · doi:10.1042/bj3030825 · Cited by 37
Site‐directed mutagenesis of β‐lactamase TEM‐1
Lenfant, F., Petit-Paitel, A., Labia, R., Maveyraud, L., Samama, J., & Masson, J. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb18324.x · Cited by 37
Carbapenems and SHV-1 β-Lactamase Form Different Acyl-Enzyme Populations in Crystals and Solution
Kalp, M., & CAREY, P. R. (2008) · Biochemistry · doi:10.1021/bi800833u · Cited by 37
Using Steric Hindrance to Design New Inhibitors of Class C β-Lactamases
Trehan, I., Morandi, F., Blaszczak, L. C., & Shoichet, B. K. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00211-9 · Cited by 37
Clavulanic acid inhibition of .BETA.-lactamase I from Bacillus cereus 569/H.
Durkin, J. P., & Viswanatha, T. (1978) · The Journal of Antibiotics · doi:10.7164/antibiotics.31.1162 · Cited by 37
Evaluation of β-Lactamase Inhibitors in Disk Tests for Detection of Plasmid-Mediated AmpC β-Lactamases in Well-Characterized Clinical Strains of Klebsiella spp
Black, J. A., Thomson, K. S., Buynak, J. D., & Pitout, J. D. D. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.8.4168-4171.2005 · Cited by 37
4-Substituted Trinems as Broad Spectrum β-Lactamase Inhibitors: Structure-Based Design, Synthesis, and Biological Activity
Plantan, I., Selič, L., Mesar, T., Anderluh, P. Š., Oblak, M., Preželj, A., Hesse, L., Andrejašič, M., Vilar, M., Turk, D., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0703237 · Cited by 36
Structural and Biochemical Characterization of the Interaction between KPC-2 β-Lactamase and β-Lactamase Inhibitor Protein,
Hanes, M. S., Jude, K. M., Berger, J. M., Bonomo, R. A., & Handel, T. M. (2009) · Biochemistry · doi:10.1021/bi9007963 · Cited by 36
Self-citation
Critical hydrogen bonding by serine 235 for cephalosporinase activity of TEM-1 beta-lactamase
Imtiaz, U., Manavathu, E. K., Lerner, S. A., & Mobashery, S. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.11.2438 · Cited by 36
New system based on site-directed mutagenesis for highly accurate comparison of resistance levels conferred by SHV beta-lactamases
Nüesch‐Inderbinen, M., Hächler, H., & Kayser, F. H. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.8.1726 · Cited by 36
SHV-49, a Novel Inhibitor-Resistant β-Lactamase in a Clinical Isolate of Klebsiella pneumoniae
Dubois, V., Poirel, L., Arpin, C., Coulange, L., Bébéar, C., Nordmann, P., & Quentin, C. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.11.4466-4469.2004 · Cited by 36
In vitro antibacterial activity and mechanism of action of J-111,225, a novel 1β-methylcarbapenem, against transferable IMP-1 metallo-β-lactamase producers
Nagano, R., Adachi, Y., Hashizume, T., & Morishima, H. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.3.271 · Cited by 36
Novel IMP-1 metallo-β-lactamase inhibitors can reverse meropenem resistance inEscherichia coliexpressing IMP-1
Moloughney, J. G., Thomas, J. D., & Toney, J. H. (2004) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2004.11.042 · Cited by 35
Ampicillin-Sulbactam and Amoxicillin-Clavulanate Susceptibility Testing of Escherichia coli Isolates with Different β-Lactam Resistance Phenotypes
Oliver, A., Pérez-Vázquez, M. D., Martínez-Ferrer, M., Baquero, F., Rafael, L., & Cantón, R. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.4.862 · Cited by 35
OHIO-1 β-lactamase resistant to mechanism-based inactivators
Bonomo, R. A. (1992) · FEMS Microbiology Letters · doi:10.1016/0378-1097(92)90545-y · Cited by 34
Self-citation
Potentiation of beta-lactams against Pseudomonas aeruginosa strains by Ro 48-1256, a bridged monobactam inhibitor of AmpC beta-lactamases
Livermore, D. M. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.3.335 · Cited by 34
Inhibition of OXA-1 β-Lactamase by Penems
Bethel, C. R., Distler, A. M., Ruszczycky, M. W., Carey, M. P., CAREY, P. R., Hujer, A. M., Taracila, M., Helfand, M. S., Thomson, J. M., Kalp, M., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01677-07 · Cited by 33
Self-citation
Unexpected Advanced Generation Cephalosporinase Activity of the M69F Variant of SHV β-Lactamase
Helfand, M. S., Hujer, A. M., Sönnichsen, F. D., & Bonomo, R. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207271200 · Cited by 33
Self-citation
Clavnlanate and -lactamase induction
Livermore, D. M., Akova, M., Wu, P., & Yang, Y. (1989) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/24.suppl_b.23 · Cited by 33
Preparation of the 7-oxo-4-oxa-1-azabicyclo[3.2.0]hept-2-ene system and the reversible cleavage of its oxazoline ring
Cherry, P. C., Newall, C. E., & Watson, N. S. (1978) · Journal of the Chemical Society Chemical Communications · doi:10.1039/c39780000469 · Cited by 33
Imipenem as substrate and inhibitor of β-lactamases
Monks, J., & Waley, S. G. (1988) · Biochemical Journal · doi:10.1042/bj2530323 · Cited by 32
Novel mechanism of inhibiting β-Lactamases by sulfonylation using β-Sultams
Page, M. I., Hinchliffe, P. S., Wood, J. M., Harding, L. P., & Laws, A. P. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.08.082 · Cited by 32
Approaches to the simultaneous inactivation of metallo- and serine-β-lactamases
Ganta, S., Perumal, S. K., Pagadala, S. R. R., Samuelsen, Ø., SPENCER, J. M., Pratt, R. F., & Buynak, J. D. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.02.018 · Cited by 32
Substitution of Asp for Asn at Position 132 in the Active Site of TEM β -Lactamase
Osuna, J., Viadiu, H., Fink, A. L., & Soberón, X. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.775 · Cited by 32
Inhibitor resistant class A beta-lactamases
Bonomo, R. A. (1999) · Frontiers in bioscience · doi:10.2741/a477 · Cited by 32
Self-citation
TEM-109 (CMT-5), a Natural Complex Mutant of TEM-1 β-Lactamase Combining the Amino Acid Substitutions of TEM-6 and TEM-33 (IRT-5)
Robin, F., Delmas, J., Chanal, C., Sirot, D., Sirot, J., & Bonnet, R. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4443-4447.2005 · Cited by 32
Comparative evaluation of the inhibitory activities of the novel penicillanic acid sulfone Ro 48-1220 against beta-lactamases that belong to groups 1, 2b, and 2be
TZOUVELEKIS, L. S., Gazouli, M., Prinarakis, E. E., Tzelepi, Ε., & Legakis, N. J. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.2.475 · Cited by 32
Overcoming Resistance to β-Lactamase Inhibitors: Comparing Sulbactam to Novel Inhibitors against Clavulanate Resistant SHV Enzymes with Substitutions at Ambler Position 244
Thomson, J. M., Distler, A. M., & Bonomo, R. A. (2007) · Biochemistry · doi:10.1021/bi700792a · Cited by 31
Self-citation
Molecular epidemiology of an outbreak due to IRT-2 -lactamase-producing strains of Klebsiella pneumoniae in a geriatric department
Girlich, D., Karim, A., Poirel, L., Cavin, M.-H., Verny, C., & Nordmann, P. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.4.467 · Cited by 31
In Vitro and In Vivo Activities of Syn2190, a Novel β-Lactamase Inhibitor
Nishida, K., Kunugita, C., Uji, T., Higashitani, F., Hyodo, A., Unemi, N., Maiti, S. N., Phillips, O. A., Spevak, P., Atchison, K. P., et al. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.8.1895 · Cited by 31
Inactivation of CMY-2 β-lactamase by tazobactam: initial mass spectroscopic characterization
Bonomo, R. A., Liu, J., Chen, Y., Ng, L., Hujer, A. M., & Anderson, V. E. (2001) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(01)00175-3 · Cited by 30
Self-citation
Inhibition of β-Lactamase in Neisseria gonorrhoeae by Sodium Clavulanate
Miller, J. M., Baker, C. N., & Thornsberry, C. (1978) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.14.5.794 · Cited by 30
Kinetic study of interaction between BRL 42715, beta-lactamases, and D-alanyl-D-alanine peptidases
Matagne, A., Ledent, P., Monnaie, D., Felici, A., Jamin, M., Raquet, X., Galleni, M., Klein, D., FRANCOIS, I., & Frère, J.-M. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.1.227 · Cited by 30
In Vitro Activities of Novel Oxapenems, Alone and in Combination with Ceftazidime, against Gram-Positive and Gram-Negative Organisms
Jamieson, C., Lambert, P. A., & Simpson, I. N. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2615-2618.2003 · Cited by 30
Antibiotic Treatment of Anaerobic Infections
Gorbach, S. L. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.supplement_4.s305 · Cited by 29
Clavulanic acid, a novel beta-lactamase inhibitor--a case study in drug discovery and development.
BROWN, A. G. (1986) · PubMed · Cited by 29
Molecular and Biochemical Characterization of SHV-56, a Novel Inhibitor-Resistant β-Lactamase fromKlebsiella pneumoniae
Dubois, V., Poirel, L., Demarthe, F., Arpin, C., Coulange, L., Minarini, L. A. D. R., Bezian, M. C., Nordmann, P., & Quentin, C. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00387-08 · Cited by 28

Research works printed but not linked: 14

Danel, F., M. G. Page, and D. M. Livermore. 2007. Class D β-lactamases, p. 163-194. In R. A. Bonomo and M. E. Tolmasky (ed.), Enzyme-mediated resistance to antibiotics: mechanisms, dissemination, and prospects for inhibition. ASM Press, Washington, DC.
Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother. 2007
Dubus, A., P. Ledent, J. Lamotte-Brasseur, and J. M. Frere. 1996. The roles of residues Tyr150, Glu272, and His314 in class C β-lactamases. Proteins25:473-485.
Foulds, G., W. E. Barth, J. R. Bianchine, A. R. English, D. Girard, S. L. Hayes, M. O'Brien, and P. Somani. 1980. Pharmacokinetics of CP-45.899 and pro-drug CP-47.904 in animals and humans, p. 353-356. In J. D. Nelson and C. Grassi (ed.), Current chemotherapy and infectious disease. American Society for Microbiology, Washington DC.
Galleni, M., and J. M. Frere. 2007. Kinetics of β-lactamases and pencillin-binding proteins, p. 195-213. In R. A. Bonomo and M. E. Tolmasky (ed.), Enzyme-mediated resistance to antibiotics: mechanisms, dissemination, and prospects for inhibition. ASM Press, Washington, DC.
F1-310. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother. 2007
F1-333a. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother. 2007
Livermore, D. M., M. Akova, P. J. Wu, and Y. J. Yang. 1989. Clavulanate and β-lactamase induction. J. Antimicrob. Chemother.24(Suppl. B):23-33.
A1-006. Abstr. 49th Intersci. Conf. Antimicrob. Agents Chemother. 2009
Meroueh, S., J. Cha, and S. Mobashery. 2007. Inhibition of class A β-lactamases, p. 101-114. In R. A. Bonomo and M. E. Tolmasky (ed.), Enzyme-mediated resistance to antibiotics: mechanisms, dissemination, and prospects for inhibition. ASM Press, Washingtion, DC.
Page, M. G. 2007. Resistance mediated by penicllin-binding proteins, p. 81-99. In R. A. Bonomo and M. E. Tolmasky (ed.), Enzyme-mediated resistance to antibiotics: mechanisms, dissemination, and prospects for Inhibition. ASM Press, Washington, DC.
F1-311. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother. 2007
F1-0882. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother. 2007
Slocombe, B., A. S. Beale, R. J. Boon, K. E. Griffin, P. J. Masters, R. Sutherland, and A. R. White. 1984. Antibacterial activity in vitro and in vivo of amoxicillin in the presence of clavulanic acid, p. 29-49. InProgress and perspectives on β-lactamase inhibition: a review of Augmentin. Custom Communications: Postgraduate Medicine, New York, NY.

Sorted by citations

Antibiotic resistance-the need for global solutions
Laxminarayan, R., Duse, A., Wattal, C., Zaidi, A. K. M., Wertheim, H. F. L., Sumpradit, N., Vlieghe, E., Hara, G. L., Gould, I. M., Goossens, H., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70318-9 · Cited by 4,439
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies
Pang, Z., Raudonis, R., Glick, B. R., Lin, T., & Cheng, Z. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.11.013 · Cited by 2,520
Resistance of Gram-Negative Bacteria to Current Antibacterial Agents and Approaches to Resolve It
Breijyeh, Z., Jubeh, B., & Karaman, R. (2020) · Molecules · doi:10.3390/molecules25061340 · Cited by 1,582
Synthesis of Heterocycles via Palladium-Catalyzed Carbonylations
Wu, X., Neumann, H., & Beller, M. (2012) · Chemical Reviews · doi:10.1021/cr300100s · Cited by 1,286
Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions
TZOUVELEKIS, L. S., Markogiannakis, A., Psichogiou, M., Tassios, P. T., & Daikos, G. L. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05035-11 · Cited by 1,190

See all 1,709

Authors: Drawz, S. M., & Bonomo, R. A.
Affiliations: Departments of Pathology
United States Department of Veterans Affairs (US)
Corresponding author: Bonomo, Robert A.
ORCID: Bonomo, Robert A.
Venue: Clinical Microbiology Reviews
Publisher: American Society for Microbiology
Published: 2010-01
Volume: 23
Issue: 1
Pages: 160-201
ISSN: 0893-8512 (ISSN-L)
1098-6618
DOI: 10.1128/cmr.00037-09
PMC: PMC2806661
OpenAlex: W1895007034
Cited by: 1,709
References: 464
Citations by year: 2026: 83 · 2025: 100 · 2024: 87 · 2023: 86 · 2022: 106 · 2021: 126 · 2020: 151 · 2019: 130 · 2018: 131 · 2017: 119 · 2016: 120 · 2015: 108 · 2014: 93 · 2013: 88 · 2012: 81
FWCI: 4.26
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: journals.asm.org/non-commercial-tdm-license (tdm)
Locations: Clinical Microbiology Reviews (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: U.S. Public Health Service (1R01A1063517-01)
National Institute of General Medical Sciences (T32GM007250, T32GM07250)
Topics: Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
Physical Sciences › Chemistry › Organic Chemistry › Synthesis of β-Lactam Compounds
Keywords: beta-lactamase inhibitors, beta-lactamase, beta-lactam resistance, clavulanic acid, sulbactam, tazobactam, mechanism-based inactivators, carbapenemase inhibitors, extended-spectrum cephalosporin resistance, Enterobacteriaceae, penicillin-resistant staphylococci
MeSH terms: Bacteria, Bacterial Infections, Bacterial Proteins, beta-Lactamases, Enzyme Inhibitors, Humans, beta-Lactam Resistance, beta-Lactamase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Three Decades of β-Lactamase Inhibitors

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks